551 related articles for article (PubMed ID: 20371709)
1. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
Peck B; Chen CY; Ho KK; Di Fruscia P; Myatt SS; Coombes RC; Fuchter MJ; Hsiao CD; Lam EW
Mol Cancer Ther; 2010 Apr; 9(4):844-55. PubMed ID: 20371709
[TBL] [Abstract][Full Text] [Related]
2. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
[TBL] [Abstract][Full Text] [Related]
3. Sirtinol, a class III HDAC inhibitor, induces apoptotic and autophagic cell death in MCF-7 human breast cancer cells.
Wang J; Kim TH; Ahn MY; Lee J; Jung JH; Choi WS; Lee BM; Yoon KS; Yoon S; Kim HS
Int J Oncol; 2012 Sep; 41(3):1101-9. PubMed ID: 22751989
[TBL] [Abstract][Full Text] [Related]
4. Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL).
Bhalla S; Gordon LI
Cancer Biol Ther; 2016; 17(3):300-9. PubMed ID: 26794150
[TBL] [Abstract][Full Text] [Related]
5. Salermide up-regulates death receptor 5 expression through the ATF4-ATF3-CHOP axis and leads to apoptosis in human cancer cells.
Liu G; Su L; Hao X; Zhong N; Zhong D; Singhal S; Liu X
J Cell Mol Med; 2012 Jul; 16(7):1618-28. PubMed ID: 21801305
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SIRT1/2 upregulates HSPA5 acetylation and induces pro-survival autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells.
Mu N; Lei Y; Wang Y; Wang Y; Duan Q; Ma G; Liu X; Su L
Apoptosis; 2019 Oct; 24(9-10):798-811. PubMed ID: 31321634
[TBL] [Abstract][Full Text] [Related]
7. Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor.
Park JB
PLoS One; 2016; 11(3):e0150392. PubMed ID: 26986569
[TBL] [Abstract][Full Text] [Related]
8. Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.
Ponnusamy M; Zhou X; Yan Y; Tang J; Tolbert E; Zhao TC; Gong R; Zhuang S
J Pharmacol Exp Ther; 2014 Aug; 350(2):243-56. PubMed ID: 24833701
[TBL] [Abstract][Full Text] [Related]
9. Hit-to-lead optimization on aryloxybenzamide derivative virtual screening hit against SIRT.
Yagci S; Gozelle M; Kaya SG; Ozkan Y; Aksel AB; Bakar-Ates F; Dundar Y; Eren G
Bioorg Med Chem; 2021 Jan; 30():115961. PubMed ID: 33360574
[TBL] [Abstract][Full Text] [Related]
10. Javamide-I-O-methyl ester increases p53 acetylation and induces cell death via activating caspase 3/7 in monocytic THP-1 cells.
Park JB
Phytomedicine; 2016 Dec; 23(13):1647-1652. PubMed ID: 27823629
[TBL] [Abstract][Full Text] [Related]
11. A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
Hoffmann G; Breitenbücher F; Schuler M; Ehrenhofer-Murray AE
J Biol Chem; 2014 Feb; 289(8):5208-16. PubMed ID: 24379401
[TBL] [Abstract][Full Text] [Related]
12. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.
Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037
[TBL] [Abstract][Full Text] [Related]
13. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
[TBL] [Abstract][Full Text] [Related]
14. The central Sirtuin 1/p53 pathway is essential for the orexigenic action of ghrelin.
Velásquez DA; Martínez G; Romero A; Vázquez MJ; Boit KD; Dopeso-Reyes IG; López M; Vidal A; Nogueiras R; Diéguez C
Diabetes; 2011 Apr; 60(4):1177-85. PubMed ID: 21386086
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding.
Park EY; Woo Y; Kim SJ; Kim DH; Lee EK; De U; Kim KS; Lee J; Jung JH; Ha KT; Choi WS; Kim IS; Lee BM; Yoon S; Moon HR; Kim HS
Int J Biol Sci; 2016; 12(12):1555-1567. PubMed ID: 27994519
[TBL] [Abstract][Full Text] [Related]
16. Discovery of salermide-related sirtuin inhibitors: binding mode studies and antiproliferative effects in cancer cells including cancer stem cells.
Rotili D; Tarantino D; Nebbioso A; Paolini C; Huidobro C; Lara E; Mellini P; Lenoci A; Pezzi R; Botta G; Lahtela-Kakkonen M; Poso A; Steinkühler C; Gallinari P; De Maria R; Fraga M; Esteller M; Altucci L; Mai A
J Med Chem; 2012 Dec; 55(24):10937-47. PubMed ID: 23189967
[TBL] [Abstract][Full Text] [Related]
17. CBX8 suppresses Sirtinol-induced premature senescence in human breast cancer cells via cooperation with SIRT1.
Lee SH; Um SJ; Kim EJ
Cancer Lett; 2013 Jul; 335(2):397-403. PubMed ID: 23474493
[TBL] [Abstract][Full Text] [Related]
18. A New Synthetic Histone Deacetylase Inhibitor, MHY2256, Induces Apoptosis and Autophagy Cell Death in Endometrial Cancer Cells via p53 Acetylation.
De U; Son JY; Sachan R; Park YJ; Kang D; Yoon K; Lee BM; Kim IS; Moon HR; Kim HS
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30217020
[TBL] [Abstract][Full Text] [Related]
19. Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells.
Li P; Zhang L; Zhou C; Lin N; Liu A
J Toxicol Sci; 2015; 40(5):615-24. PubMed ID: 26354378
[TBL] [Abstract][Full Text] [Related]
20. EX527, a Sirt-1 inhibitor, induces apoptosis in glioma via activating the p53 signaling pathway.
Wang T; Li X; Sun SL
Anticancer Drugs; 2020 Jan; 31(1):19-26. PubMed ID: 31490284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
